Skip to Main Content

Paper Details

Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): A 2-year randomized controlled trial.
Diabetes Obes Metab
6
2021
Author NameAffiliation
Bernard ZinmanMount Sinai Hospital
Bernard ZinmanUniversity of Toronto
Bernard ZinmanLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
  • 1 - 3

Datasets

Release 1.2